| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11136-004-0832-9 |
| P698 | PubMed publication ID | 16022065 |
| P50 | author | Dennis A Revicki | Q91415021 |
| P2093 | author name string | Louis S Matza | |
| Anne M Rentz | |||
| Andrine Swensen | |||
| Kristina Secnik | |||
| P2860 | cites work | Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study | Q32041865 |
| The Child Health Questionnaire in Australia: reliability, validity and population means | Q59598061 | ||
| Methylphenidate and hyperactivity: effects on teacher behaviors | Q71198102 | ||
| A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder | Q71819060 | ||
| Development of a Spanish (Castillian) version of the Childhood Health Assessment Questionnaire. Measurement of health status in children with juvenile chronic arthritis | Q73573807 | ||
| ADHD in Swedish 3- to 7-year-old children | Q74511976 | ||
| Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life | Q33845173 | ||
| A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder | Q33923100 | ||
| GW320659 for the treatment of attention-deficit/hyperactivity disorder in children | Q34142782 | ||
| Quality-of-life measures in chronic diseases of childhood. | Q34191710 | ||
| Recommendations on health-related quality of life research to support labeling and promotional claims in the United States | Q34205886 | ||
| Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorders institution | Q34249371 | ||
| Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology | Q34339837 | ||
| Can parents rate their child's health-related quality of life? Results of a systematic review | Q34474977 | ||
| The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata | Q34508205 | ||
| Methods to explain the clinical significance of health status measures | Q34590636 | ||
| Parental report of health-related quality of life in children with sickle cell disease | Q34676982 | ||
| Assessing meaningful change in quality of life over time: a users' guide for clinicians | Q34680524 | ||
| Current approaches to assessing the quality of life in children and adolescents | Q35041619 | ||
| Development and validation of a disease‐specific treatment satisfaction questionnaire for gastro‐oesophageal reflux disease | Q35583055 | ||
| Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues | Q35627969 | ||
| "Clinical Global Impressions" (ECDEU): some critical comments | Q38472817 | ||
| Use of the child health questionnaire in a sample of moderate and low-income inner-city children with asthma | Q39549541 | ||
| Recommendations for evaluating the validity of quality of life claims for labeling and promotion | Q40328237 | ||
| Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. | Q42679957 | ||
| An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder | Q42687765 | ||
| A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder | Q43657283 | ||
| Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study | Q43789283 | ||
| Effect sizes for interpreting changes in health status. | Q43872888 | ||
| The parent-form Child Health Questionnaire in Australia: comparison of reliability, validity, structure, and norms | Q47661447 | ||
| Attention-Deficit/Hyperactivity symptoms in Icelandic schoolchildren: assessment with the Attention Deficit/Hyperactivity Rating Scale-IV. | Q47687076 | ||
| Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results | Q47753451 | ||
| The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology | Q48878079 | ||
| Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria | Q48882934 | ||
| Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. | Q51947880 | ||
| Elementary school-aged children's reports of their health: a cognitive interviewing study. | Q51964379 | ||
| Defining clinically meaningful change in health-related quality of life. | Q52013966 | ||
| Bupropion hydrochloride in attention deficit disorder with hyperactivity. | Q52046328 | ||
| Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool. | Q52121824 | ||
| Measuring change over time: assessing the usefulness of evaluative instruments. | Q52608136 | ||
| Measurement of health outcomes in treatment effectiveness evaluations: conceptual and methodological challenges. | Q53513123 | ||
| Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. | Q53539831 | ||
| P433 | issue | 3 | |
| P921 | main subject | questionnaire | Q747810 |
| teenager | Q1492760 | ||
| attention | Q6501338 | ||
| attention deficit hyperactivity disorder | Q181923 | ||
| child health | Q57354899 | ||
| P304 | page(s) | 719-734 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Quality of Life Research | Q15749950 |
| P1476 | title | Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder | |
| P478 | volume | 14 |
| Q38480352 | A 6-Month, Open-Label, Extension Study of the Tolerability and Effectiveness of the Methylphenidate Transdermal System in Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder |
| Q51915852 | Agreement between parent and child report of quality of life in children with attention-deficit/hyperactivity disorder. |
| Q48158585 | Agreement between pediatric brain tumor patients and parent proxy reports regarding the Pediatric Functional Assessment of Cancer Therapy-Childhood Brain Tumor Survivors questionnaire, version 2. |
| Q38814353 | Annual Research Review: Quality of life and childhood mental and behavioural disorders - a critical review of the research |
| Q38262758 | Applying a developmental approach to quality of life assessment in children and adolescents with psychological disorders: challenges and guidelines |
| Q97067312 | Assessing quality of life in psychosocial and mental health disorders in children: a comprehensive overview and appraisal of generic health related quality of life measures |
| Q36755295 | Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review |
| Q64087242 | Assessment of the Effects of Pediatric Attention Deficit Hyperactivity Disorder on Family Stress and Well-Being: Development of the IMPACT 1.0 Scale |
| Q30572111 | Behavioural sleep problems in children with attention-deficit/hyperactivity disorder (ADHD): protocol for a prospective cohort study |
| Q40785630 | Comorbidity and correlates of disruptive mood dysregulation disorder in 6-8-year-old children with ADHD. |
| Q34098654 | Determinants of reduced health-related quality of life in pediatric inherited neuropathies |
| Q33552633 | Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? |
| Q37092901 | Effect of dexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study |
| Q37623195 | Effect of pain in pediatric inherited neuropathies |
| Q33695037 | Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder |
| Q39295740 | Estimating minimal important differences for several scales assessing function and quality of life in patients with attention-deficit/hyperactivity disorder |
| Q39028113 | Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective ove |
| Q37980687 | Health-related quality of life among children with mental disorders: a systematic review |
| Q46902579 | Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample |
| Q36738305 | Health-related quality-of-life measures for long-term follow-up in children after major trauma |
| Q37763165 | Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD. |
| Q36471058 | Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline |
| Q46486344 | Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications |
| Q37272547 | Measurement properties of multidimensional patient-reported outcome measures in neurodisability: a systematic review of evaluation studies. |
| Q27007856 | Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials |
| Q22061981 | Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) |
| Q41791034 | Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies |
| Q48081299 | Otitis Media and Caregiver Quality of Life: Psychometric Properties of the Modified Danish Version of the Caregiver Impact Questionnaire |
| Q38537323 | Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes |
| Q53112609 | Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates. |
| Q49060049 | Quality of life in children with Charcot-Marie-Tooth disease |
| Q48632411 | Relationship between symptoms of attention-deficit/hyperactivity disorder and family functioning: a community-based study |
| Q47697825 | Reliability and Validity of The Cerebral Palsy Quality of Life Questionnaire in The Turkish Population |
| Q40338508 | Service use in children aged 6-8 years with attention deficit hyperactivity disorder |
| Q60644396 | The Family Strain Index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD |
| Q34464728 | The Otitis Media-6 questionnaire: psychometric properties with emphasis on factor structure and interpretability. |
| Q34598924 | The PedsQL as a patient-reported outcome in children and adolescents with Attention-Deficit/Hyperactivity Disorder: a population-based study |
| Q37788677 | The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review |
| Q48078133 | The prevalence of attention-deficit/hyperactivity disorder following neonatal aortic arch repair |
| Q35084047 | The quality of life of children with attention deficit/hyperactivity disorder: a systematic review |
| Q34554876 | Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences |
| Q34902405 | Validation of Pediatric Functional Assessment of Cancer Therapy Questionnaire (Version 2.0) in Brain Tumor Survivor Aged 13 Years and Older (Parent Form)(PedsFACT-BrS Parent of Adolescent). |
| Q51913596 | Validation of a Portuguese version of a generic health quality-of-life questionnaire for children with neurological and neuropsychiatric disorders, including epilepsy. |
| Q64997133 | Validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD) in a sample of Turkish non-ambulatory children with cerebral palsy. |
| Q39271511 | Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition |
Search more.